CITADEL ADVISORS LLC 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:14 am Purchase |
2022-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
CITADEL ADVISORS LLC | 2,849,354 4.500% |
360,070 (+14.46%) |
Filing |
| 2022-01-13 4:28 pm Purchase |
2022-01-03 | 13G | Edgewise Therapeutics, Inc. EWTX |
CITADEL ADVISORS LLC | 2,489,284 5.000% |
30,761 (+1.25%) |
Filing |
| 2022-01-13 4:27 pm Purchase |
2021-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
CITADEL ADVISORS LLC | 2,458,523 5.000% |
3,199 (+0.13%) |
Filing |
| 2021-07-12 4:07 pm Purchase |
2021-07-01 | 13G | Edgewise Therapeutics, Inc. EWTX |
CITADEL ADVISORS LLC | 2,455,324 5.000% |
2,455,324 (New Position) |
Filing |